Eisai CoESALF 74 Forward Dividend Yield % is 4.05% as of Jun. 24, 2026. GuruFocus rates ESALF with a GF Score™ of 74/100 and a GF Value™ of $36.60 (Significantly Undervalued). The stock has 7 warning signs investors should review. Among 503 Drug Manufacturers companies, Eisai Co ranks better than 79.32% on this metric.
As of today (2026-06-24), the Forward Annual Dividend Yield of Eisai Co is 4.05%.
As of today (2026-06-24), the Trailing Annual Dividend Yield of Eisai Co is 4.07%.
ESALF's Forward Dividend Yield % is ranked better than 79.32% of 503
companies
in the Drug Manufacturers industry
Industry Median: 2.1
vs ESALF: 4.05
During the past 10 years, the average Dividends Per Share Growth Rate was 0.80% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Eisai Co was 49.40% per year. The lowest was 0.00% per year. And the median was 2.20% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Eisai Co (OTCPK:ESALF) Forward Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
For the Drug Manufacturers - Specialty & Generic subindustry, Eisai Co's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Eisai Co Forward Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Eisai Co's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Eisai Co's Forward Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Eisai Co Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
JPY 80.000000
2026-03-30
2026-03-31
2026-06-01
Cash Dividend
semi-annually
JPY:USD 0.006286
JPY 80.000000
2025-09-29
2025-09-30
2025-11-18
Cash Dividend
semi-annually
JPY:USD 0.006758
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Eisai Co's Forward Annual Dividend Yield (%) for Today is calculated as
Forward Annual Dividend Yield
=
Forward Full Year Dividend
/
Current Share Price
=
1.00576
/
25.00
=
4.02 %
Current Share Price is $25.00. Eisai Co's Dividends per Share for the forward twelve months is calculated as $0.50288 * 2 = $1.00576.
Eisai Co's Trailing Annual Dividend Yield (%) for Today is calculated as
Trailing Annual Dividend Yield
=
Most Recent Full Year Dividend
/
Current Share Price
=
1.04352
/
25.00
=
4.17 %
Current Share Price is $25.00. Eisai Co's Dividends per Share for the trailing twelve months (TTM) ended in Today is $1.04352.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Forward Dividend Yield % of 4.05% mean?
Eisai Co (ESALF) has a Forward Dividend Yield % of 4.05% as of Jun. 24, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Eisai Co and its competitors. According to the industry distribution chart, Eisai Co ranks #104 out of 503 companies in the Drug Manufacturers industry, placing it in the top 20.7%.
Is Eisai Co's Forward Dividend Yield % too high?
Eisai Co's current Forward Dividend Yield % is 4.05%. The Drug Manufacturers industry median Forward Dividend Yield % is 2.10. Eisai Co's value of 4.05% is 92.9% above this industry median. Based on the distribution chart, Eisai Co ranks #104 out of 503 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Eisai Co has a GF Score™ of 74/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Eisai Co's Forward Dividend Yield % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Eisai Co ranks #104 out of 503 companies for Forward Dividend Yield %. This places Eisai Co in the top 21% of its industry — outperforming the majority of peers. The industry median Forward Dividend Yield % is 2.10. Eisai Co's value of 4.05% is 92.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Drug Manufacturers company?
The median Forward Dividend Yield % among Drug Manufacturers companies is 2.10, based on 503 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Eisai Co's current Forward Dividend Yield % of 4.05% is 92.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Eisai Co and its competitors. For the Drug Manufacturers industry, the median Forward Dividend Yield % is 2.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Eisai Co's current Forward Dividend Yield % is 4.05%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eisai Co stock overvalued right now?
Based on GuruFocus' analysis, Eisai Co (ESALF) is currently considered Significantly Undervalued. The stock's GF Value™ is $36.60, compared to a current price of $25.00 — trading 31.7% below its estimated fair value. The current Forward Dividend Yield % is 4.05% and 92.9% above the Drug Manufacturers industry median of 2.10. Eisai Co's overall GF Score™ is 74/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Eisai Co (ESALF), the current Forward Dividend Yield % is 4.05% as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Eisai Co (ESALF) Overvalued in 2026?
Based on GuruFocus' analysis, Eisai Co stock appears to be undervalued.
The current stock price of $25.00 is trading 31.7% below its estimated GF Value™ of $36.60.
GuruFocus considers Eisai Co to be Significantly Undervalued.
Key valuation signals for ESALF:
Forward Dividend Yield %: 4.05%
GF Value™: $36.60 vs. price of $25.00 (31.7% below fair value)
Industry Position: 92.9% above the Drug Manufacturers median (#104 of 503)
No single metric tells the full story. See the ESALF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Eisai Co Ltd is a specialty and generic drug manufacturing company. The company's business consists of research and development, manufacturing, sales, import, and export of pharmaceuticals. The pharmaceutical business is categorized by region, including East Asia & Global South; Europe, Middle East, Africa, Russia, Oceania (EMEA); Americas; China; and Japan. The company also reports a consumer healthcare business for Japan. The vast majority of the company's revenue is derived from its American pharmaceutical business, followed by its Japanese pharmaceuticals segment. The company utilizes licensing strategies in order to expand its research, development, manufacturing, and marketing capabilities.
74GF Score
Get the complete analysis for ESALF
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ESALF has been successfully added to your 